Longboard Pharmaceuticals Company Profile, Contacts & Intelligence

Biotechnology Research4275 Executive Square37 employeesFounded 2020
3 contacts with email or phone data3 with email data2 with phone data
View verified contacts Compare competitors
Employees
37
Company source estimate
Reachable Contacts
3
Visible contacts with email or phone data
Contacts With Email
3
3 of 4 visible contacts
Departments
5
Mapped contact coverage

Longboard Pharmaceuticals Overview

Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases. Longboard is working to advance a portfolio of centrally acting product candidates designed to be highly selective for specific G protein-coupled receptors (GPCRs). Longboard’s small molecule product candidates are based on more than 20 years of GPCR research. Longboard plans to advance bexicaserin (LP352), an oral, centrally acting 5-hydroxytryptamine 2C (5-HT2C) receptor superagonist, with no observed impact on 5-HT2B and 5-HT2A receptor subtypes, into a global Phase 3 program. Longboard recently reported positive topline data from a Phase 1b/2a clinical trial (the PACIFIC Study) evaluating bexicaserin in participants ages 12 to 65 years old with Developmental and Epileptic Encephalopathies (DEEs), including Lennox-Gastaut syndrome, Dravet syndrome and other DEEs. Longboard is also evaluating LP659, an oral, centrally acting, sphingosine-1-phosphate (S1P) receptor subtypes 1 and 5 modulator, which is in development for the potential treatment of rare neuroinflammatory conditions.

Headquarters
4275 Executive Square
Website
longboardpharma.com
Industry
Biotechnology Research
Founded
2020
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Phone Number
Available in AeroLeads
Company Email
Available in AeroLeads
Representative jobs

Longboard Pharmaceuticals Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

3 contacts with contact data
3 with email data and 2 with phone data in the visible sample.
5 departments represented
Visible contacts with email or phone data are mapped to these departments.
3 company-domain emails
Visible contacts using Longboard Pharmaceuticals's company email domain.
General
6
Healthcare
5
Executive
1
Operations
1
Legal
1

Longboard Pharmaceuticals People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

J
Jane Tiller Frcpsych (Md), Mba, Mphil
M
Michelle Almeida
Vice President, Assistant General Counsel, Contracts and Operations at Longboard Pharmaceuticals
EP
C
Casey Lynch
Executive, Director, Investor
EP
C
Corinne M. Le Goff, Pharm.d., M.b.a.
Chief Commercial Officer at Viatris - Non-executive Board Director - Forbes 2021 “Women Changing the World”
E

Longboard Pharmaceuticals Workforce Composition

Seniority breakdown across 23 visible profiles.

Executive
4
Senior / Lead
4
Associate / junior
4
Director
3
Individual contributor
3
Manager
2
Intern / trainee
2
VP / Head
1

Longboard Pharmaceuticals Technology & Talent

Technology-related job titles represented in the visible people data.

Data / AI
2

Compare Similar Companies to Longboard Pharmaceuticals

Explore companies in related markets and compare their industry and employee estimates.

Company Industry / match Employee estimate Page
Vertex Pharmaceuticals Biotechnology Research 6.09K View company
Lundbeck Pharmaceutical Manufacturing 5.99K View company
Neurocrine Biosciences Biotechnology Research 1.98K View company
Avidity Biosciences, Inc. Biotechnology 491 View company
Sage Therapeutics Biotechnology Research 451 View company
Poseida Therapeutics, Inc. Biotechnology Research 218 View company
RayzeBio Biotechnology Research 216 View company
Morphic Therapeutic Pharmaceutical Manufacturing 56 View company
Dermata Therapeutics, Inc. Biotechnology Research 9 View company
Bright Minds Biosciences Biotechnology Research 8 View company